Mount Sinai Doctors
Accepting New Patients
Joshua Friedman, MD
Neurology
About Me
Joshua Friedman, MD is an Assistant Professor in the Departments of Neurology, Neurosurgery and Internal Medicine (Division of Hematology and Oncology). He is board certified in both neurology and neuro-oncology and welcomes patients with primary and metastatic cancers of the brain, spinal cord, nerves, and meninges, as well as the neurologic complications of systemic cancer. At Ruttenberg Treatment Center, his team is dedicated to diagnosing and providing compassionate care to patients suffering from a variety of brain and spinal cord tumors including glioma and glioblastoma, CNS lymphoma, meningioma, and metastases from other primary cancers.
Dr. Friedman studied neurobiology at Harvard University and subsequently completed medical school at the Icahn School of Medicine at Mount Sinai where he was the recipient of the Dr. Morris B. Bender Award in Clinical Neurology. He completed his medical internship and neurology residency at the Icahn School of Medicine at Mount Sinai. Dr. Friedman then subspecialized by completing a two year fellowship in neuro-oncology at Memorial Sloan Kettering Cancer Center.
Dr. Friedman is developing a leading liquid biopsy program to revolutionize how we diagnose, monitor, and evaluate brain tumors. To this end, he applies techniques of obtaining tumor pathology from a minimally invasive lumbar puncture that can be used for diagnosis, disease response monitoring, and tracking tumor evolution. Dr. Friedman’s research in collaboration with the Departments of Pathology and Genomics aims to uncover a new mechanism for understanding the genomic landscape of glioma. Additionally, a significant portion of Dr. Friedman’s research focuses on leading clinical research trials for both primary and metastatic brain cancers to help develop an extensive translational clinical research portfolio that provides patients an array of therapeutic trial options.
Dr. Friedman conducts visits in person or via telemedicine based on the unique needs of each patient.
Language
Position
Hospital Affiliations
- Mount Sinai Beth Israel
- Mount Sinai Morningside
- Mount Sinai Brooklyn
- Mount Sinai Queens
- The Mount Sinai Hospital
- Mount Sinai West
About Me
Joshua Friedman, MD is an Assistant Professor in the Departments of Neurology, Neurosurgery and Internal Medicine (Division of Hematology and Oncology). He is board certified in both neurology and neuro-oncology and welcomes patients with primary and metastatic cancers of the brain, spinal cord, nerves, and meninges, as well as the neurologic complications of systemic cancer. At Ruttenberg Treatment Center, his team is dedicated to diagnosing and providing compassionate care to patients suffering from a variety of brain and spinal cord tumors including glioma and glioblastoma, CNS lymphoma, meningioma, and metastases from other primary cancers.
Dr. Friedman studied neurobiology at Harvard University and subsequently completed medical school at the Icahn School of Medicine at Mount Sinai where he was the recipient of the Dr. Morris B. Bender Award in Clinical Neurology. He completed his medical internship and neurology residency at the Icahn School of Medicine at Mount Sinai. Dr. Friedman then subspecialized by completing a two year fellowship in neuro-oncology at Memorial Sloan Kettering Cancer Center.
Dr. Friedman is developing a leading liquid biopsy program to revolutionize how we diagnose, monitor, and evaluate brain tumors. To this end, he applies techniques of obtaining tumor pathology from a minimally invasive lumbar puncture that can be used for diagnosis, disease response monitoring, and tracking tumor evolution. Dr. Friedman’s research in collaboration with the Departments of Pathology and Genomics aims to uncover a new mechanism for understanding the genomic landscape of glioma. Additionally, a significant portion of Dr. Friedman’s research focuses on leading clinical research trials for both primary and metastatic brain cancers to help develop an extensive translational clinical research portfolio that provides patients an array of therapeutic trial options.
Dr. Friedman conducts visits in person or via telemedicine based on the unique needs of each patient.
Language
Position
Hospital Affiliations
- Mount Sinai Beth Israel
- Mount Sinai Morningside
- Mount Sinai Brooklyn
- Mount Sinai Queens
- The Mount Sinai Hospital
- Mount Sinai West
Clinical Focus
- Astrocytoma
- Brain / Nervous System Cancer
- Brain Tumor And Brain Cancer
- Brain Tumor And Brain Cancer-Adult
- Brain Tumors
- Cancer Treatment
- Glioblastoma Multiforme
- Lumbar Puncture
- Oncology Second Opinion
Show More
Education
MD, Icahn School of Medicine at Mount Sinai
Residency, Neurology
Icahn School of Medicine At Mount Sinai
Fellowship, Neuro-oncology
Memorial Sloan-Kettering Cancer Center
Locations
Insurance Information
Accepted insurance may vary by the doctor’s office location. Please contact the office directly to obtain the most up-to-date insurance information.
Patients with Cigna Medicare Advantage or Humana Medicare Advantage insurance: Please read this important message before booking to find out if out-of-network costs may apply to your next visit.
- Ruttenberg Treatment Center1470 Madison Avenue, Third Floor, New York, NY, 10029
Physicians who provide services at hospitals and facilities in the Mount Sinai Health System might not participate in the same health plans as those Mount Sinai hospitals and facilities (even if the physicians are employed or contracted by those hospitals or facilities).
Information regarding insurance participation and billing by this physician may be found on this page, and can also be obtained by contacting this provider directly. Because physicians insurance participation can change, the insurance information on this page may not always be up-to-date. Please contact this physician directly to obtain the most up-to-date insurance information.
Insurance and health plan networks that the various Mount Sinai Health System hospitals and facilities participate in can be found on the Mount Sinai Health System website.
Industry Relationships
Physicians and scientists on the faculty of the Icahn School of Medicine at Mount Sinai often interact with pharmaceutical, device, biotechnology companies, and other outside entities to improve patient care, develop new therapies and achieve scientific breakthroughs. In order to promote an ethical and transparent environment for conducting research, providing clinical care and teaching, Mount Sinai requires that salaried faculty inform the School of their outside financial relationships.
Dr. Friedman has not yet completed reporting of Industry relationships.
Mount Sinai's faculty policies relating to faculty collaboration with industry are posted on our website. Patients may wish to ask their physician about the activities they perform for companies.
Physicians and scientists on the faculty of the Icahn School of Medicine at Mount Sinai often interact with pharmaceutical, device, biotechnology companies, and other outside entities to improve patient care, develop new therapies and achieve scientific breakthroughs. In order to promote an ethical and transparent environment for conducting research, providing clinical care and teaching, Mount Sinai requires that salaried faculty inform the School of their outside financial relationships.
Dr. Friedman has not yet completed reporting of Industry relationships.
Mount Sinai's faculty policies relating to faculty collaboration with industry are posted on our website. Patients may wish to ask their physician about the activities they perform for companies.